Goleta breast implant developer Sientra announced plans to streamline its miraDry operations and acquire its Opus brand manufacturer from Lubrizol Life Science for $20 million in cash. In an accompanying earnings statement, the company also hiked up its guidance for the year after a quarter in which sales rose 33 percent and net losses beat…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
